369 related articles for article (PubMed ID: 24096265)
21. Downregulation of ErbB3 by Wnt3a contributes to wnt-induced osteoblast differentiation in mesenchymal cells.
Jullien N; Maudinet A; Leloutre B; Ringe J; Häupl T; Marie PJ
J Cell Biochem; 2012 Jun; 113(6):2047-56. PubMed ID: 22274864
[TBL] [Abstract][Full Text] [Related]
22. Protective effects of miR-29a on diabetic glomerular dysfunction by modulation of DKK1/Wnt/β-catenin signaling.
Hsu YC; Chang PJ; Ho C; Huang YT; Shih YH; Wang CJ; Lin CL
Sci Rep; 2016 Jul; 6():30575. PubMed ID: 27460630
[TBL] [Abstract][Full Text] [Related]
23. miR-365 Ameliorates Dexamethasone-Induced Suppression of Osteogenesis in MC3T3-E1 Cells by Targeting HDAC4.
Xu D; Gao Y; Hu N; Wu L; Chen Q
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28471397
[TBL] [Abstract][Full Text] [Related]
24. miR-29a promotes osteoblast proliferation by downregulating DKK-1 expression and activating Wnt/β-catenin signaling pathway.
Zhang F; Cao K; Du G; Zhang Q; Yin Z
Adv Clin Exp Med; 2019 Oct; 28(10):1293-1300. PubMed ID: 31538414
[TBL] [Abstract][Full Text] [Related]
25. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity.
Fu Y; Zhang P; Ge J; Cheng J; Dong W; Yuan H; Du Y; Yang M; Sun R; Jiang H
Int J Biochem Cell Biol; 2014 Sep; 54():68-77. PubMed ID: 25019367
[TBL] [Abstract][Full Text] [Related]
26. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
[TBL] [Abstract][Full Text] [Related]
27. Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass.
Wang FS; Lin CL; Chen YJ; Wang CJ; Yang KD; Huang YT; Sun YC; Huang HC
Endocrinology; 2005 May; 146(5):2415-23. PubMed ID: 15677765
[TBL] [Abstract][Full Text] [Related]
28. MiR-29a promotes osteogenic differentiation of mesenchymal stem cells via targeting HDAC4.
Tan K; Peng YT; Guo P
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3318-3326. PubMed ID: 29917181
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-29a Counteracts Glucocorticoid Induction of Bone Loss through Repressing TNFSF13b Modulation of Osteoclastogenesis.
Wu RW; Lian WS; Chen YS; Kuo CW; Ke HC; Hsieh CK; Wang SY; Ko JY; Wang FS
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31627291
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-10a Influences Osteoblast Differentiation and Angiogenesis by Regulating β-Catenin Expression.
Li J; Zhang Y; Zhao Q; Wang J; He X
Cell Physiol Biochem; 2015; 37(6):2194-208. PubMed ID: 26610149
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-17/20a inhibits glucocorticoid-induced osteoclast differentiation and function through targeting RANKL expression in osteoblast cells.
Shi C; Qi J; Huang P; Jiang M; Zhou Q; Zhou H; Kang H; Qian N; Yang Q; Guo L; Deng L
Bone; 2014 Nov; 68():67-75. PubMed ID: 25138550
[TBL] [Abstract][Full Text] [Related]
32. Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor.
Luzi E; Marini F; Sala SC; Tognarini I; Galli G; Brandi ML
J Bone Miner Res; 2008 Feb; 23(2):287-95. PubMed ID: 18197755
[TBL] [Abstract][Full Text] [Related]
33. Heat shock protein 60 protects skeletal tissue against glucocorticoid-induced bone mass loss by regulating osteoblast survival.
Wang FS; Wu RW; Ko JY; Tai MH; Ke HC; Yeh DW; Wu SL; Chen MW
Bone; 2011 Nov; 49(5):1080-9. PubMed ID: 21854881
[TBL] [Abstract][Full Text] [Related]
34. Let-7f-5p regulates TGFBR1 in glucocorticoid-inhibited osteoblast differentiation and ameliorates glucocorticoid-induced bone loss.
Shen GY; Ren H; Shang Q; Zhao WH; Zhang ZD; Yu X; Huang JJ; Tang JJ; Yang ZD; Liang D; Jiang XB
Int J Biol Sci; 2019; 15(10):2182-2197. PubMed ID: 31592234
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-29a represses osteoclast formation and protects against osteoporosis by regulating PCAF-mediated RANKL and CXCL12.
Lian WS; Ko JY; Chen YS; Ke HJ; Hsieh CK; Kuo CW; Wang SY; Huang BW; Tseng JG; Wang FS
Cell Death Dis; 2019 Sep; 10(10):705. PubMed ID: 31543513
[TBL] [Abstract][Full Text] [Related]
36. Microtubule actin crosslinking factor 1 promotes osteoblast differentiation by promoting β-catenin/TCF1/Runx2 signaling axis.
Hu L; Su P; Yin C; Zhang Y; Li R; Yan K; Chen Z; Li D; Zhang G; Wang L; Miao Z; Qian A; Xian CJ
J Cell Physiol; 2018 Feb; 233(2):1574-1584. PubMed ID: 28621459
[TBL] [Abstract][Full Text] [Related]
37. LRP8 mediates Wnt/β-catenin signaling and controls osteoblast differentiation.
Zhang J; Zhang X; Zhang L; Zhou F; van Dinther M; Ten Dijke P
J Bone Miner Res; 2012 Oct; 27(10):2065-74. PubMed ID: 22589174
[TBL] [Abstract][Full Text] [Related]
38. Wnt16 is involved in intramembranous ossification and suppresses osteoblast differentiation through the Wnt/β-catenin pathway.
Jiang Z; Von den Hoff JW; Torensma R; Meng L; Bian Z
J Cell Physiol; 2014 Mar; 229(3):384-92. PubMed ID: 24037946
[TBL] [Abstract][Full Text] [Related]
39. Synergistic actions of insulin-sensitive and Sirt1-mediated pathways in the differentiation of mouse embryonic stem cells to osteoblast.
Srivastava S; Bedi U; Roy P
Mol Cell Endocrinol; 2012 Sep; 361(1-2):153-64. PubMed ID: 22542761
[TBL] [Abstract][Full Text] [Related]
40. The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma.
Yuan JH; Yang F; Chen BF; Lu Z; Huo XS; Zhou WP; Wang F; Sun SH
Hepatology; 2011 Dec; 54(6):2025-35. PubMed ID: 21837748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
